Cargando…
TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancer
This study aimed to identify novel prognostic biomarker for advanced renal cell carcinoma (RCC) patients treated with anti-PD-1 therapy, using quantitative multi-immunofluorescence (IF) analysis of tumor immunity. Twenty-five consecutive patients who had metastatic or unresectable RCC treated with a...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586238/ https://www.ncbi.nlm.nih.gov/pubmed/33129110 http://dx.doi.org/10.1016/j.tranon.2020.100918 |